Wells Fargo’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-520,000
| Closed | -$28M | – | 7201 |
|
|
2025
Q4 | $28M | Buy |
+520,000
| New | +$25M | 0.01% | 1265 |
|
|
2025
Q3 | – | Sell |
-100,500
| Closed | -$4.65M | – | 7098 |
|
|
2025
Q2 | $4.65M | Sell |
100,500
-4,500
| -4% | -$221K | ﹤0.01% | 2535 |
|
|
2025
Q1 | $6.4M | Buy |
105,000
+100,000
| +2,000% | +$5.83M | ﹤0.01% | 2215 |
|
|
2024
Q4 | $283K | Hold |
5,000
| – | – | ﹤0.01% | 4573 |
|
|
2024
Q3 | $259K | Hold |
5,000
| – | – | ﹤0.01% | 4405 |
|
|
2024
Q2 | $208K | Hold |
5,000
| – | – | ﹤0.01% | 4500 |
|
|
2024
Q1 | $271K | Sell |
5,000
-66,300
| -93% | -$3.38M | ﹤0.01% | 4277 |
|
|
2023
Q4 | $3.66M | Sell |
71,300
-270,000
| -79% | -$14.2M | ﹤0.01% | 2448 |
|
|
2023
Q3 | $19.8M | Sell |
341,300
-156,600
| -31% | -$9.6M | 0.01% | 1095 |
|
|
2023
Q2 | $31.8M | Buy |
497,900
+153,100
| +44% | +$10.3M | 0.01% | 880 |
|
|
2023
Q1 | $23.9M | Sell |
344,800
-117,800
| -25% | -$8.31M | 0.01% | 1020 |
|
|
2022
Q4 | $33.3M | Buy |
462,600
+2,600
| +0.6% | +$196K | 0.01% | 839 |
|
|
2022
Q3 | $32.7M | Hold |
460,000
| – | – | 0.01% | 825 |
|
|
2022
Q2 | $35.4M | Hold |
460,000
| – | – | 0.01% | 833 |
|
|
2022
Q1 | $33.6M | Buy |
460,000
+192,400
| +72% | +$12.9M | 0.01% | 982 |
|
|
2021
Q4 | $16.7M | Buy |
267,600
+190,000
| +245% | +$11.1M | ﹤0.01% | 1474 |
|
|
2021
Q3 | $4.59M | Sell |
77,600
-40,000
| -34% | -$2.63M | ﹤0.01% | 2910 |
|
|
2021
Q2 | $7.86M | Sell |
117,600
-30,000
| -20% | -$1.96M | ﹤0.01% | 2436 |
|
|
2021
Q1 | $9.32M | Sell |
147,600
-335,000
| -69% | -$20.8M | ﹤0.01% | 2253 |
|
|
2020
Q4 | $363K | Sell |
482,600
-60,100
| -11% | -$3.7M | ﹤0.01% | 4752 |
|
|
2020
Q3 | $1.44M | Buy |
542,700
+20,000
| +4% | +$1.2M | ﹤0.01% | 3580 |
|
|
2020
Q2 | $2.55M | Buy |
522,700
+54,100
| +12% | +$3.24M | ﹤0.01% | 3082 |
|
|
2020
Q1 | $3.16M | Sell |
468,600
-302,000
| -39% | -$18.5M | ﹤0.01% | 2622 |
|
|
2019
Q4 | $1.53M | Buy |
770,600
+231,400
| +43% | +$13.3M | ﹤0.01% | 3555 |
|
|
2019
Q3 | $265K | Buy |
539,200
+154,400
| +40% | +$7.26M | ﹤0.01% | 4788 |
|
|
2019
Q2 | $906K | Buy |
384,800
+384,300
| +76,860% | +$17.9M | ﹤0.01% | 3935 |
|
|
2019
Q1 | $4K | Sell |
500
-17,400
| -97% | -$867K | ﹤0.01% | 5764 |
|
|
2018
Q4 | $70K | Sell |
17,900
-43,900
| -71% | -$2.36M | ﹤0.01% | 5424 |
|
|
2018
Q3 | $97K | Buy |
61,800
+17,900
| +41% | +$1.06M | ﹤0.01% | 5367 |
|
|
2018
Q2 | $158K | Buy |
43,900
+25,700
| +141% | +$1.39M | ﹤0.01% | 5153 |
|
|
2018
Q1 | $35K | Buy |
18,200
+17,900
| +5,967% | +$1.15M | ﹤0.01% | 5667 |
|
|
2017
Q4 | $1K | Buy |
+300
| New | +$18.8K | ﹤0.01% | 6238 |
|
|
2017
Q2 | – | Sell |
-1,510
| Closed | -$4K | – | 6219 |
|
|
2017
Q1 | $4K | Sell |
1,510
-380,990
| -100% | -$20.9M | ﹤0.01% | 6062 |
|
|
2016
Q4 | $822K | Buy |
382,500
+330,000
| +629% | +$18M | ﹤0.01% | 3838 |
|
|
2016
Q3 | $547K | Buy |
52,500
+7,500
| +17% | +$482K | ﹤0.01% | 3902 |
|
|
2016
Q2 | $81K | Sell |
45,000
-800
| -2% | -$56.5K | ﹤0.01% | 4950 |
|
|
2016
Q1 | $231K | Hold |
45,800
| – | – | ﹤0.01% | 4316 |
|
|
2015
Q4 | $201K | Buy |
45,800
+45,000
| +5,625% | +$2.97M | ﹤0.01% | 4459 |
|
|
2015
Q3 | $2K | Sell |
800
-300
| -27% | -$19K | ﹤0.01% | 5977 |
|
|
2015
Q2 | $1K | Sell |
1,100
-8,300
| -88% | -$547K | ﹤0.01% | 6219 |
|
|
2015
Q1 | $6K | Buy |
9,400
+1,800
| +24% | +$113K | ﹤0.01% | 5768 |
|
|
2014
Q4 | $18K | Sell |
7,600
-3,300
| -30% | -$186K | ﹤0.01% | 5399 |
|
|
2014
Q3 | $10K | Buy |
10,900
+10,500
| +2,625% | +$524K | ﹤0.01% | 5571 |
|
|
2014
Q2 | $1K | Sell |
400
-14,800
| -97% | -$729K | ﹤0.01% | 5993 |
|
|
2014
Q1 | $20K | Buy |
15,200
+3,700
| +32% | +$197K | ﹤0.01% | 5224 |
|
|
2013
Q4 | $4K | Buy |
11,500
+1,700
| +17% | +$86.6K | ﹤0.01% | 5407 |
|
|
2013
Q3 | $7K | Buy |
9,800
+9,200
| +1,533% | +$404K | ﹤0.01% | 5198 |
|
|
2013
Q2 | $2K | Buy |
+600
| New | +$26K | ﹤0.01% | 5366 |
|
Other funds holding BMY
VCM
VPM
Wells Fargo's BMY Position: Q1 2026 in Review
Wells Fargo increased its Bristol-Myers Squibb (BMY) stake by 0.12% in Q1 2026, buying an estimated $422K and bringing the position to 5,946,447 shares worth $361M. The position accounts for 0.07% of the portfolio, ranked #250.
Wells Fargo first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.07B in Q2 2016. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Wells Fargo held 5,946,447 shares of Bristol-Myers Squibb worth $361M as of Q1 2026.
- Wells Fargo bought 7,244 Bristol-Myers Squibb shares in Q1 2026, an estimated $422K.
- Bristol-Myers Squibb made up 0.07% of Wells Fargo's portfolio in Q1 2026, its #250 holding.
- Wells Fargo first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Bristol-Myers Squibb position peaked at $1.07B in Q2 2016.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.